Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Alzheimer Disease l: Introduction

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Spatial single-cell multiomics reveals peripheral immune dysfunction in Parkinson's and inflammatory bowel disease.

NPJ Parkinson's disease·2026

Same author

Single-cell multiomics identifies both shared and unique features of immune dysfunction in Parkinson's disease and inflammatory bowel disease colon, plasma and stool.

bioRxiv : the preprint server for biology·2025

Same author

Effects of iron accumulation and its chelation on oxidative stress in intracortical implants.

Acta biomaterialia·2025

Same author

Ferroptosis and pathogenesis of neuritic plaques in Alzheimer disease.

Pharmacological reviews·2025

Same author

Detection of molecular markers of ferroptosis in human Alzheimer's disease brains.

Journal of Alzheimer's disease : JAD·2024

Same author

Ferroptosis and pathogenesis of neuritic plaques in Alzheimer's Disease.

Pharmacological reviews·2024

Same journal

Molecular changes during AT/RT progression associated with epithelial-mesenchymal transition and extracellular matrix changes.

Acta neuropathologica·2026

Same journal

Prion-like transmission and propagation of human β-amyloid to the bank vole rodent model.

Acta neuropathologica·2026

Same journal

Inhibition of tRNA fragments dysregulated in human mTLE exacerbates pathology and seizure activity.

Acta neuropathologica·2026

Same journal

VMA21 deficiency leads to autophagic dysregulation and altered vesicle trafficking in X-linked myopathy with excessive autophagy.

Acta neuropathologica·2026

Same journal

Donor-specific pathological features associate with genetic background, lesion type distribution, and clinical heterogeneity in multiple sclerosis.

Acta neuropathologica·2026

Same journal

Tau368 improves p-tau diagnostic accuracy for FTLD-tau from FTLD-TDP.

Acta neuropathologica·2026

See all related articles

Search research articles

Related Experiment Video

Updated: May 30, 2026

Correlative Light and Electron Microscopy to Study Microglial Interactions with β-Amyloid Plaques

Correlative Light and Electron Microscopy to Study Microglial Interactions with β-Amyloid Plaques

Published on: June 1, 2016

Microglial pathology in Down syndrome.

Qing-Shan Xue¹, Wolfgang J Streit

¹Department of Neuroscience, McKnight Brain Institute, University of Florida College of Medicine, PO Box 100244, Gainesville, FL, 32610-0244, USA.

Acta Neuropathologica

|August 18, 2011

Summary

This summary is machine-generated.

Down syndrome (DS) brains show degenerating microglia, not activated ones, alongside Alzheimer

More Related Videos

In Vitro Modeling of Down Syndrome Neurogenesis Using Human-Induced Pluripotent Stem Cells

In Vitro Modeling of Down Syndrome Neurogenesis Using Human-Induced Pluripotent Stem Cells

Published on: March 7, 2025

In Vivo Dynamics of Retinal Microglial Activation During Neurodegeneration: Confocal Ophthalmoscopic Imaging and Cell Morphometry in Mouse Glaucoma

In Vivo Dynamics of Retinal Microglial Activation During Neurodegeneration: Confocal Ophthalmoscopic Imaging and Cell Morphometry in Mouse Glaucoma

Published on: May 11, 2015

Related Experiment Videos

Last Updated: May 30, 2026

Correlative Light and Electron Microscopy to Study Microglial Interactions with β-Amyloid Plaques

Correlative Light and Electron Microscopy to Study Microglial Interactions with β-Amyloid Plaques

Published on: June 1, 2016

In Vitro Modeling of Down Syndrome Neurogenesis Using Human-Induced Pluripotent Stem Cells

In Vitro Modeling of Down Syndrome Neurogenesis Using Human-Induced Pluripotent Stem Cells

Published on: March 7, 2025

In Vivo Dynamics of Retinal Microglial Activation During Neurodegeneration: Confocal Ophthalmoscopic Imaging and Cell Morphometry in Mouse Glaucoma

In Vivo Dynamics of Retinal Microglial Activation During Neurodegeneration: Confocal Ophthalmoscopic Imaging and Cell Morphometry in Mouse Glaucoma

Published on: May 11, 2015

Area of Science:

Neuroscience
Pathology
Gerontology

Background:

Down syndrome (DS) is a human model for Alzheimer's disease (AD) due to inevitable AD pathology development.
Neuroinflammation, specifically microglial activation, is widely considered a key driver of neurodegeneration in AD and DS.
Previous research suggests dystrophic (senescent) microglia, rather than activated ones, are present in AD and DS brains.

Purpose of the Study:

To analyze microglial senescence pathology in the temporal cortices of individuals with Down syndrome.
To investigate the relationship between microglial degeneration and tau pathology in DS.
To determine the state of microglia (activated vs. senescent) in DS brains during the onset of AD-like changes.

Main Methods:

Analysis of temporal cortex tissue from 6 Down syndrome cases in their 40s.
Immunostaining using Iba1 and anti-ferritin markers to identify and characterize microglial cells.
Quantification of normal, activated, and dystrophic microglial populations.
Assessment of colocalization between dystrophic microglia and tau pathology.

Main Results:

Consistent presence of dystrophic microglial cells and absence of activated microglia in DS subjects with tau pathology.
Significant decrease in normal microglia numbers (19-85% reduction compared to controls) in DS brains.
Nearly all ferritin-positive microglia exhibited dystrophic morphology, with severe cases showing cytorrhexis (cell fragmentation).
Dystrophic microglia were frequently found near tau-positive senile plaques.

Conclusions:

Microglial degeneration, characterized by senescence and fragmentation, is closely linked to neurofibrillary degeneration in Down syndrome.
Microglial degeneration appears to be a progressive event that parallels the advancement of Alzheimer's disease-like changes in DS.
These findings challenge the traditional view of detrimental neuroinflammation and highlight microglial senescence as a critical factor in DS neurodegeneration.